AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 13c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.48), $0.13 better than the analyst estimate of ($0.61).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• Apple alleges defendant in trade secret case against OpenAI accessed power converter circuit schematic while at OpenAI - legal filing
• Silver Storm closes $21M private placement with second tranche
• Frontier Airlines to return 13 aircraft early, lease 10 new jets